Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Onchocerca volvulus | |
References | |
Onchocerca volvulus | Chitinase | Starlite/ChEMBL | References |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Entamoeba histolytica | chitinase, putative | 0.0091 | 0.2004 | 0.5 |
Loa Loa (eye worm) | cuticular endochitinase | 0.0091 | 0.2004 | 0.2004 |
Brugia malayi | Endochitinase | 0.0102 | 0.3645 | 0.2052 |
Plasmodium vivax | hypothetical protein, conserved | 0.0144 | 1 | 0.5 |
Toxoplasma gondii | hypothetical protein | 0.0144 | 1 | 0.5 |
Loa Loa (eye worm) | chitinase I | 0.0091 | 0.2004 | 0.2004 |
Plasmodium falciparum | conserved protein, unknown function | 0.0144 | 1 | 0.5 |
Brugia malayi | endochitinase | 0.0102 | 0.3645 | 0.2052 |
Loa Loa (eye worm) | hypothetical protein | 0.0144 | 1 | 1 |
Leishmania major | chitinase | 0.0091 | 0.2004 | 0.5 |
Onchocerca volvulus | 0.0144 | 1 | 1 | |
Onchocerca volvulus | Putative endochitinase | 0.0102 | 0.3645 | 0.2052 |
Loa Loa (eye worm) | hypothetical protein | 0.0144 | 1 | 1 |
Onchocerca volvulus | 0.0144 | 1 | 1 | |
Mycobacterium ulcerans | chitinase/cellulase | 0.0078 | 0 | 0.5 |
Mycobacterium ulcerans | chitinase/cellulase | 0.0078 | 0 | 0.5 |
Echinococcus granulosus | Hepatocellular carcinoma associated antigen 59 | 0.0144 | 1 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0144 | 1 | 0.5 |
Mycobacterium tuberculosis | Possible chitinase | 0.0078 | 0 | 0.5 |
Echinococcus multilocularis | Hepatocellular carcinoma associated antigen 59 | 0.0144 | 1 | 0.5 |
Loa Loa (eye worm) | microfilarial chitinase | 0.0088 | 0.1641 | 0.1641 |
Onchocerca volvulus | Putative endochitinase | 0.0102 | 0.3645 | 0.2052 |
Onchocerca volvulus | Putative endochitinase | 0.0102 | 0.3645 | 0.2052 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Drug uptake (ADMET) | Drug accumulation in Caenorhabditis elegans at 10 uM after 6 hrs by LC-MS analysis | ChEMBL. | 24918716 | |
IC50 (binding) | = 0.6 uM | Inhibition of Onchocerca volvulus L3 larvae chitinase using 20 uM 4-methylumbelliferyl-N,N',N''-beta-chitotrioside as substrate after 10 mins by microplate reader analysis | ChEMBL. | 24918716 |
Inhibition (functional) | Antiparasitic activity against Onchocerca volvulus assessed as inhibition of L3 to L4 larval molting at 100 uM for 24 hrs measured until 6 days by using inverted microscopic analysis in presence of PBMC | ChEMBL. | 24918716 | |
Inhibition (binding) | Inhibition of Onchocerca volvulus L3 larvae chitinase using 20 uM 4-methylumbelliferyl-N,N',N''-beta-chitotrioside as substrate at 10 uM after 10 mins by microplate reader analysis | ChEMBL. | 24918716 | |
Inhibition (functional) | Antiparasitic activity against Onchocerca volvulus assessed as inhibition of L3 to L4 larval molting at 0.5 uM for 24 hrs measured until 6 days by using inverted microscopic analysis in presence of PBMC and 0.5 uM protonophore CCCP | ChEMBL. | 24918716 | |
Inhibition (functional) | Antiparasitic activity against Onchocerca volvulus assessed as inhibition of L3 to L4 larval molting at 2.5 uM for 24 hrs measured until 6 days by using inverted microscopic analysis in presence of PBMC and 2.5 uM protonophore CCCP | ChEMBL. | 24918716 | |
Inhibition (functional) | Antiparasitic activity against Onchocerca volvulus assessed as inhibition of L3 to L4 larval molting at 10 uM for 24 hrs measured until 6 days by using inverted microscopic analysis in presence of PBMC | ChEMBL. | 24918716 | |
Inhibition (functional) | Antiparasitic activity against Onchocerca volvulus assessed as inhibition of L3 to L4 larval molting at 1 uM for 24 hrs measured until 6 days by using inverted microscopic analysis in presence of PBMC and 1 uM protonophore CCCP | ChEMBL. | 24918716 | |
Inhibition (functional) | Antiparasitic activity against Onchocerca volvulus assessed as inhibition of L3 to L4 larval molting at 1 uM for 24 hrs measured until 6 days by using inverted microscopic analysis in presence of PBMC | ChEMBL. | 24918716 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.